Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China · Delayed Price · Currency is CNY 31.94
-0.55 (-1.69%)
At close: Aug 24, 2026
SHA:603014 Market Cap
SHA:603014 has a market cap or net worth of 13.57 billion as of August 24, 2026. Its market cap has decreased by -16.48% in one year.
Market Cap
13.57B
Enterprise Value
10.81B
Revenue
3.78B
Ranking
n/a
PE Ratio
27.11
Stock Price
31.94
ChartMarket Cap Chart
Since May 19, 2025, SHA:603014's market cap has decreased from 17.04B to 13.57B, a decrease of -20.33%. That is a compound annual growth rate of -16.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 13.57B | -18.02% |
| Dec 31, 2025 | 16.56B | -2.82% |
| May 19, 2025 | 17.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autobio Diagnostics | 19.77B |
| Double Medical Technology | 18.07B |
| MeHow Innovative | 13.39B |
| Jafron Biomedical | 12.20B |
| Shanghai MicroPort Endovascular MedTech | 11.17B |
| Beijing Balance Medical Technology | 10.81B |
| Cofoe Medical Technology | 10.58B |
| Shanghai MicroPort EP MedTech | 9.51B |